Management of UTI in a Patient with Indwelling Ureteral Stent
This patient requires immediate empiric broad-spectrum antibiotic therapy for catheter-associated pyelonephritis, with levofloxacin 750 mg once daily being the preferred first-line agent, and the stent should be replaced at the time of removal in six days if it has been in place for ≥2 weeks. 1
Immediate Management Steps
Obtain Cultures Before Antibiotics
- Collect a urine culture specimen immediately prior to initiating antimicrobial therapy, as stent-associated infections have a wide spectrum of potential organisms with increased likelihood of antimicrobial resistance 1
- The sensitivity of urine culture alone for detecting stent colonization is only 40%, meaning a negative urine culture does not rule out a colonized stent 2
- In patients with indwelling stents, 60% of those with positive stent cultures have sterile urine cultures, highlighting the discordance between urine and stent bacteriology 2
Clinical Diagnosis
This patient has pyelonephritis (not simple cystitis) based on:
- Fever with flank pain indicating upper tract involvement 3
- Systemic symptoms (nausea) suggesting kidney infection 4
- Urinalysis showing significant pyuria (75 leukocytes/µL), bacteriuria, and hematuria 5
- Positive nitrites, which are highly specific for bacterial infection, particularly in the context of symptoms 5
Antibiotic Selection
First-Line Empiric Therapy
Levofloxacin 750 mg once daily is the recommended first-line agent for this patient with mild-to-moderate catheter-associated UTI who is not severely ill 1. This recommendation is based on:
- Superior microbiologic eradication rates compared to other regimens 1
- Excellent tissue penetration for pyelonephritis 3
- Once-daily dosing improving compliance 1
Alternative Regimens
If the patient appears severely ill or has risk factors for multidrug resistance:
- Use combination therapy with amoxicillin plus an aminoglycoside 4
- Or a second-generation cephalosporin plus an aminoglycoside 4
- Or an intravenous third-generation cephalosporin 4, 3
Avoid These Agents
- Do not use moxifloxacin due to uncertainty regarding effective urinary concentrations 1
- Avoid ciprofloxacin for empirical treatment if the patient has used fluoroquinolones in the last 6 months or has been in a urology department, due to high resistance rates 1
- Do not use nitrofurantoin for pyelonephritis, as it does not achieve adequate tissue levels in the kidney parenchyma 3
Stent Management Strategy
Timing of Stent Removal
- Proceed with planned stent removal in six days as scheduled 4
- If the stent has been in place for ≥2 weeks, replace it at the time of removal to hasten symptom resolution and reduce risk of subsequent infection 1
- Collect urine culture from the freshly placed catheter if feasible, as biofilm on older catheters may not accurately reflect true bladder infection status 1
Why Stent Replacement Matters
- Stent colonization occurs in 42% of patients with indwelling stents 2
- Bacteria on colonized stents are significantly more resistant to antibiotics than organisms isolated before stent insertion 2
- Patients with positive stent cultures have 5.7 times higher odds of developing clinical UTI within 12 months compared to those with negative cultures 6
Antibiotic Duration
Standard Duration
Treat for 7 days if the patient shows prompt resolution of symptoms 1. This applies to:
- Defervescence within 48-72 hours 4
- Resolution of flank pain 3
- Clinical improvement in overall condition 1
Extended Duration
Extend treatment to 10-14 days if there is delayed response, regardless of whether the catheter remains in place 1. Indicators for extended therapy include:
- Persistent fever beyond 72 hours 4
- Continued flank pain or systemic symptoms 3
- Lack of clinical improvement 1
Adjusting Therapy Based on Culture Results
When Results Return
- Modify antibiotics based on culture and susceptibility results when available 1
- The most common isolates from stent-associated infections are E. coli, Enterococcus spp., Staphylococcus spp., Pseudomonas, and Candida spp. 2, 7
- Stent isolates demonstrate higher resistance rates than pre-stent urine cultures 2
If No Clinical Improvement by 72 Hours
- Consider extending treatment duration 1
- Perform urologic evaluation to assess for complications such as obstruction or abscess 1
- Obtain repeat imaging if indicated 4
Special Considerations for This Patient
Risk Factors Present
This patient has several factors increasing infection risk:
- Indwelling stent in place (duration unknown, but removal planned suggests >1 week) 2
- Positive nitrites indicating gram-negative bacteria, likely E. coli 5, 7
- Upper tract involvement (pyelonephritis) increasing risk of complications 3
Common Pitfalls to Avoid
- Do not delay catheter replacement if the stent has been in place for ≥2 weeks, as this is crucial for treatment success 1
- Do not rely solely on urine culture to guide therapy, as 60% of colonized stents have negative urine cultures 2
- Do not treat asymptomatic bacteriuria if discovered incidentally, but this patient is clearly symptomatic 4
- Do not use short-course (3-day) therapy for pyelonephritis, even though it may be appropriate for simple cystitis 1, 3
Monitoring Response
- Expect defervescence within 48-72 hours of appropriate antibiotic therapy 4
- Resolution of flank pain should occur within several days 3
- If fever persists beyond 72 hours, consider imaging to evaluate for complications such as perinephric abscess or obstruction 4
Prophylaxis Considerations
At Time of Stent Removal
- No routine antimicrobial prophylaxis is recommended for simple cystoscopic stent removal in asymptomatic patients 4
- However, this patient is symptomatic and requires therapeutic (not prophylactic) antibiotics 1
- Continue therapeutic antibiotics through the stent removal procedure 4